The role of oxidative stress-related biomarkers in ascending aortic dilatation: malondialdehyde and paraoxonase-1 activity
Öz
Aim: This study aimed to evaluate the antioxidative and oxidative status of patients with ascending aortic dilatation using malondialdehyde, an oxidative stress marker, and paraoxonase-1 activity, an antioxidant enzyme.
Methods: This cross-sectional study was conducted between August and December 2020. It included 56 consecutive patients (mean age 55.3 ± 8.6 years; range 31 to 67 years; 26 males, 30 females) with ascending aortic dilatation and 33 sex-and age-matched controls (mean age 54.5 ± 10.5 years; range 32 to 67 years; 13 males, 20 females) with normal aortic diameters. All participants were evaluated using transthoracic echocardiography. Malondialdehyde was analyzed using the thiobarbituric acid assay. Paraoxonase-1 activity was measured manually using a spectrophotometer. The relation of ascending aortic dilatation with malondialdehyde levels and paraoxonase-1 activity was identified with correlation analyses.
Results: The patient group had significantly higher mean malondialdehyde than the control group (2.5 ± 1.9 μmoL/mL and 1.7 ± 0.3 μmoL/mL, respectively; p < 0.001). The patient group had significantly lower mean activity of paraoxonase-1 than the control group (18.5 ± 12.9 U/mL vs.30 ± 17.6 U/mL, respectively; p < 0.002). Serum malondialdehyde was negatively correlated with ascending aortic diameter (r = 0.293, p = 0.009). A significant negative correlation was found between the activity of serum paraoxonase-1 and ascending aortic diameter (r = -0.364, p = 0.001). Malondialdehyde levels and paraoxonase-1 activity were independent predictors of ascending aortic dilatation.
Conclusion: The results are in line with the notion that increased malondialdehyde levels indicate lipid peroxidation, and decreased paraoxonase-1 activity indicates impaired antioxidant defense. Using them may help protect against the pathophysiology of ascending aortic dilatation.
Anahtar Kelimeler
antioxidant, ascending aortic dilatation, malondialdehyde, oxidative stress, paraoxonase-1
Kaynakça
- Ramanath VS, Oh JK, Sundt TM 3rd, Eagle KA. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin Proc. 2009;84:465-81.
- Demir B, Caglar IM, Tureli Oktay H, Ozde C, Aciksari G, Ciftci S, et al. Elevated serum gamma-glutamyltransferase levels in patients with dilated ascending aorta. Anadolu Kardiyol Derg. 2014;14(2):106-14.
- Erdogan M, Polat M, Celik MC, Ozturk S, Batug S, Ozbebek YE, et al. Oxidative stress parameters in patients with ascending aortic dilatation. Turk J Med Sci. 2020;50:1323-9.
- Karakaya O, Barutcu I, Esen AM, Dogan S, Saglam M ,Karapınar H, et al. Relationship between circulating plasma matrix metalloproteinase-9 (Gelatinase-B) concentration and aortic root dilatation. American Journal of Hypertension. 2006;19(4):361-5.
- Cozijnsen L, Braam RL, Waalewijn RA, Schepens MA, Loeys BL, van Oosterhout MF, et al. What is new in dilatation of the ascending aorta? Review of current literature and practical advice for the cardiologist. Circulation. 2011;123:924-8.
- Galis ZS, Asanuma K, Godin D, Meng X. N-acetyl-cysteine decreases the matrix- degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation. 1998;97:2445-53.
- Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol. 1997;82:291-5.
- Knight JA, Pieper RK, Mc Clellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem. 1988;34:2433-8.
- Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 1996;7:69-76.
- Schrader C, Ernst IM, Sinnecker H, Soukup ST , Kulling SE ,Rimbach G. Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo. J Cell Mol Med. 2012;16(10):2331-41.